UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 15

 

CERTIFICATION AND NOTICE OF TERMINATION OF REGISTRATION UNDER SECTION 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR SUSPENSION OF DUTY TO FILE REPORTS UNDER SECTIONS 13 AND 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934.

 

Commission File Number: 333-225962

 

Titan Medical Inc.
(Exact name of registrant as specified in its charter)
 
76 Berkeley Street, Toronto, Ontario, Canada, M5A 2W7
(Address, including zip code, and telephone number, including area code, of registrant's principal executive offices)
 
Common Shares
(Title of each class of securities covered by this Form)
 
Not Applicable
(Titles of all other classes of securities for which a duty to file reports under section 13(a) or 15(d) remains)

 

Please place an X in the box(es) to designate the appropriate rule provisions(s) relied upon to terminate or suspend the duty to file reports:

 

Rule 12g-4(a)(1) ☐
Rule 12g-4(a)(2) ☐
Rule 12h-3(b)(1)(i) ☒
Rule 12h-3(b)(1)(ii) ☐
Rule 15d-6 ☐
Rule 15d-22(b) ☐

 

Approximate number of holders of record as of the certification or notice date: 245

 

 

 

 

 

 

Pursuant to the requirements of the Securities Exchange Act of 1934 Titan Medical Inc. has caused this certification/notice to be signed on its behalf by the undersigned duly authorized person.

 

Date:  April 19, 2023 By: /s/ Cary G. Vance
    Name: Cary G. Vance
    Title: President and Chief Executive Officer

 

 

 

 

Titan Medical (PK) (USOTC:TMDIF)
Gráfico Histórico do Ativo
De Jan 2025 até Fev 2025 Click aqui para mais gráficos Titan Medical (PK).
Titan Medical (PK) (USOTC:TMDIF)
Gráfico Histórico do Ativo
De Fev 2024 até Fev 2025 Click aqui para mais gráficos Titan Medical (PK).